Asia-Pacific Plasma Therapy Market to be Worth $214 Million by 2030 - Exclusive Report by Meticulous Research®

Precision Market Research Pvt. Ltd.

The forecast for the Asia-Pacific plasma therapy market until 2030 is based on various factors such as type, application, and end user. In terms of type, the market includes pure platelet-rich plasma and platelet-rich fibrin. These two forms of plasma therapy are utilized in different applications within the medical field. The applications of plasma therapy in the Asia-Pacific region consist of orthopedics, dermatology, cosmetology, rheumatology, ophthalmology, and stomatology. Each application has its own specific requirements and purposes for using plasma therapy. Furthermore, the end users of plasma therapy in this region are primarily hospitals & clinics, as well as research institutes. These institutions play a significant role in the implementation and research of plasma therapy. It is important to note that this forecast is subject to change based on various factors such as advancements in technology, market trends, and government regulations. Continued research and development will further contribute to the growth and potential of the Asia-Pacific plasma therapy market in the coming years.

A recent market research report, 'Asia-Pacific Plasma Therapy Market, By Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology, Stomatology), and End User (Hospitals & Clinics, Research Institutes) - Forecast to 2030,' has estimated that the market for plasma therapy in the Asia-Pacific region will grow to $214 million by 2030. This growth is predicted to have a compound annual growth rate of 13.4% from 2023 to 2030.

Plasma therapy falls under the umbrella of regenerative medicine, employing injections of a patient's platelets concentration to expedite the recovery of damaged joints, ligaments, tendons, and muscles. An alternative approach, platelet-rich plasma (PRP) therapy harnesses an individual patient's innate healing capabilities to resolve musculoskeletal issues. Moreover, PRP therapy finds application in the field of cosmetics, addressing hyperpigmentation, minimizing acne scars, boosting collagen synthesis, enhancing hair health, among other benefits.

Get a complimentary sample of the report now by clicking on the following link: https://www.meticulousresearch.com/download-sample-report/cp_id=5556

The expansion of the plasma therapy market in the Asia-Pacific region can be credited to the growing recognition of platelet-rich plasma (PRP) therapy, the rise in healthcare spending in Asia-Pacific nations, and the increasing number of cosmetic procedures being performed. Nonetheless, a major obstacle faced in this market is the strict regulations governing the use of PRP, and the availability of substitute treatments and the potential side effects associated with PRP treatment may restrict the growth of the PRP therapy market to some degree in the predicted timeframe.

The rising utilization of platelet-rich plasma (PRP) therapies is creating avenues for market expansion.

As the demand for cosmetic and aesthetic procedures continues to soar, platelet-rich plasma has emerged as a leading treatment option in the field of therapeutics. Esteemed orthopedic centers and hospitals with diverse medical specialties are recognizing the effectiveness of platelet-rich plasma in alleviating pain for individuals undergoing orthopedic surgeries or dealing with ailments like arthritis, tennis knee, and tendonitis.

Moreover, the therapy can be used to treat sudden injuries caused by sports activities, such as strains in the thigh or knee. The rise in the number of sports-related injuries in the Asia-Pacific region has created chances for market expansion in recent times. To illustrate, data from the Australian Institute of Health and Welfare reveals that there were 66,500 hospitalizations in 2020–2021 due to sport-related injuries. PRP therapy has been increasingly recognized for its effectiveness in various dermatological treatments like promoting the healing of wounds, reducing scars, regenerating and rejuvenating the skin, as well as addressing alopecia.

The positive impacts of PRP in cancer treatment have also been studied. In a scientific paper published in Helion in March 2020, it was found that PRP could be a viable treatment option for bladder cancer. The study highlighted how nitric oxide can help prevent platelet clumping, which slows down the spread of cancer. This finding gives hope to cancer patients. Additionally, the increasing use of PRP in medical treatments and procedures is predicted to create growth opportunities for market players in the Asia-Pacific plasma therapy market.

Need any information? Consult with an analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5556

The report provides a detailed analysis of the major strategic advancements implemented by prominent players in the Asia-Pacific plasma therapy market from 2020 to 2023. Some of the key companies operating in this market include Arthrex, Inc. (based in the U.S.), DePuy Synthesis, Inc. (a subsidiary of Johnson & Johnson, also based in the U.S.), Global Stem Cells Group, Inc. (located in the U.S.), Terumo Corporation (headquartered in Japan), Regen Lab SA (based in Switzerland), Stryker Corporation (located in the U.S.), Zimmer Biomet Holdings, Inc. (also based in the U.S.), Exactech Inc. (headquartered in the U.S.), Beijing Manson Technology Co., Ltd. (located in China), Alocuro (based in Australia), Takeda Pharmaceutical Company Limited (headquartered in Japan), Grifols, S.A. (based in Spain), Octapharma AG (located in Switzerland), and CSL Limited (based in Australia).

The market for plasma therapy in the Asia-Pacific region is divided into different types such as Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin, and Leukocyte and Platelet-rich Fibrin. These therapies are used in various applications including Orthopedics & Traumatology, Rheumatology, Dermatology & Cosmetology, Ophthalmology, Stomatology & Odontology, and other applications. The end users of these therapies are hospitals, clinics, and research institutes. Furthermore, the study examines the competition in the industry and analyzes the market share of companies at the country level.

According to this report, the segment with the highest expected growth rate during the forecast period is leukocyte-rich PRP. This growth is mainly driven by the use of leukocyte-rich PRP to treat ankle sprains, muscle injuries, fractures, aesthetic plastic surgery, regenerative medicine, and skin and chronic wound healing. Furthermore, leukocyte- and platelet-rich plasma (L-PRP) contains high concentrations of platelets, leukocytes, and other bioactivities that play a significant role in the healing of bones and soft tissues. Therefore, the positive effects of L-PRP in certain medical applications for therapeutic purposes are predicted to be the reason behind the segment's growth in the coming years.

Fast Purchase - Market for Plasma Therapy in the Asia-Pacific Region - Global Analysis of Opportunities and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/82357590

In the analysis conducted, it is projected that the orthopedics & traumatology field will have the most significant portion of the market by 2023. This dominance can be attributed to the enhanced healing methods, reduced downtime, substantial alleviation of pain, and the utilization of minimally invasive techniques.

According to this report, it is predicted that the hospital and clinics sector will have the biggest portion of the market among all the end users by 2023. This is mainly because there will be a rise in the number of arthritis patients who will be getting PRP therapy as part of their disease management. This will result in more patients visiting hospitals and clinics. Another reason for the segment's dominance is that doctors and physicians are recommending and providing PRP treatment to patients for hair restoration due to its higher effectiveness and fewer negative effects.

In this report, it is predicted that Japan will have the biggest portion of the Asia-Pacific plasma therapy market in 2023 compared to other countries. The reason behind this is the rising number of accidents and an increasing elderly population in Japan, which is creating a higher demand for PRP therapy in fields like dermatology, orthopedics, ophthalmology, and other related uses. To illustrate this, data from the World Bank Group shows that in 2021, there were 37.4 million people aged 65 and above in Japan, indicating a growth from 34.7 million in 2015.

For a more comprehensive understanding of the market, including a detailed breakdown and visuals, please visit this link: https://www.meticulousresearch.com/product/asia-pacific-plasma-therapy-market-5556

Report Overview:

Evaluation of the Asia-Pacific Plasma Therapy Market by Category

White Blood Cell and Platelet-rich Fibrin (L-PRF)

Evaluation of Plasma Therapy Market in Asia-Pacific based on Usage In this blog post, we will be discussing the analysis and assessment of the plasma therapy market in the Asia-Pacific region, specifically focusing on its various applications.

(Additional uses comprise Sexual Well-being, Assistance with Fertility, Headache Relief, and Neurological Conditions.)

Assessment of the Plasma Therapy Market in the Asia-Pacific Region by Various User Types

Evaluation of the Plasma Therapy Market in the Asia-Pacific Region - per Nation

Rest of the Asia Pacific region

Get a complimentary sample of the report now by visiting this website: https://www.meticulousresearch.com/request-sample-report/cp_id=5556

The Global Forecast for the Plasma Therapy Market predicts the market's growth based on different types, applications, and end users. The different types of plasma therapy include pure platelet-rich plasma and platelet-rich fibrin. Applications of plasma therapy include orthopedics, dermatology, cosmetology, rheumatology, and ophthalmology. The end users of plasma therapy are hospitals and clinics, as well as research institutes.

Global Forecast to 2030: Market for Negative Pressure Wound Therapy (NPWT) According to Product (Conventional, Single-use, Accessories), Wound Type (DFU, Venous Leg Ulcer, Surgical, Burn, Skin Grafts), and End User (Hospital, Home Care).

Forecasted Global Growth of CAR T-cell Therapy Market by Different Brands (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene maraleucel], Yescarta [axicabtagene ciloleucel]) for Various Target Antigens (CD, BCMA, HER2) and Indications (Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma) till the Year 2030.

The Global Bone Growth Stimulators Market is projected to reach a substantial growth rate by the year 2030. This market is diverse and consists of various products such as Stimulation Devices (including External, Ultrasonic, and Implantable devices), Bone Morphogenetic Proteins, and Platelet Rich Plasma. These products find applications in a range of medical procedures including Spinal Fusion, Fracture treatments, and Oral Surgeries. The end users of these products are hospitals and Ambulatory Surgical Centers (ASCs). With advancements in medical technology and increasing awareness about bone growth stimulation, the market is expected to witness significant growth in the coming years.

The Recombinant Coagulation Factors Market is projected to grow and see a significant rise in the coming years. This market is categorized by different types of factors such as Factor VIII and Factor IX. Furthermore, it is distinguished by the source of these factors, which include CHO (Chinese Hamster Ovary) and HEK (Human Embryonic Kidney) sources. The application of these factors is primarily used to treat Hemophilia. Hemophilia is divided into two types: Type A and Type B. Aside from Hemophilia, there are other conditions as well where these factors play a crucial role. The end users of these products are mainly hospitals and clinical research laboratories. These establishments rely on these factors to provide proper treatment and conduct various experiments and studies. Looking ahead, the Recombinant Coagulation Factors Market is anticipated to witness significant growth and advancements until the year 2030.

Meticulous Research® emerged in 2010 and was officially established as Meticulous Market Research Pvt. Ltd. in 2013, operating as a privately held organization in accordance with the Companies Act, 1956. Since its inception, the company has developed into the foremost supplier of top-tier market insights across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Our company's name is synonymous with the services, advantages, and principles we uphold. From the very beginning, our goal has been to diligently investigate, evaluate, and present vital market information with immense precision. Through thorough primary and secondary research methods, we have developed formidable expertise in gathering, interpreting, and analyzing data, encompassing both qualitative and quantitative aspects, thanks to our exceptional team of analysts. We meticulously craft insightful and influential syndicated market research reports, customized studies, efficient research solutions, and advisory services to tackle the obstacles that hinder sustainable growth in businesses.

If you have any inquiries, please feel free to contact Mr. Khushal Bombe at Meticulous Market Research Inc. You can find our office at 1267 Willis St, Ste 200 in Redding, California, USA with zip code 96001. You can also reach us through the following phone numbers: for USA, dial +1-646-781-8004; for Europe, dial +44-203-868-8738; and for APAC, dial +91 744-7780008. Alternatively, you can send us an email at [email protected] or visit our website at https://www.meticulousresearch.com/. You can also connect with us on LinkedIn at https://www.linkedin.com/company/meticulous-research. The content source for this information can be found at https://www.meticulousresearch.com/pressrelease/786/asia-pacific-plasma-therapy-market-2030.